HIF1A and hepatocellular carcinoma: By preventing the accumulation of HIF-1α protein, most likely by targeting the AKT/mTOR pathway, CANA reduced metastasis, angiogenesis, and metabolic reprogramming in HCC (Luo et al. 2021).